" A nurse with a history of breast cancer enrolled is clinical trial C40502.  Her previous treatments included Zometa, Faslodex, and Aromasin.  She was found to have disease progression first noted by rising tumor markers."
Omulwadde ono alina ebyafaayo by’obulwadde bw’okusannyalala era nga naye abadde n’ebintu ebitali bya kusannyalala mu biseera eby’emabega. Okulondoola kwa EEG ku vidiyo kukolebwa okwekenneenya oba kukonziba kwa kusannyalala oba ebitali bya kusannyalala.